drugset / Trial / NCT00834379

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

NCT00834379

Phase 1 Completed 58 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the relative bioavailability of pravastatin sodium 40 mg tablets with that of Pravachol® 40 mg tablets in healthy adult male subjects under fasting conditions.

Timeline

Start
2000-09
Primary completion
2000-09
Completion
2000-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pravastatin Small molecule 40 mg

Indications

No indication recorded.